UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2026
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-41371
EDIBLE GARDEN AG INCORPORATED
(Exact name of registrant as specified in its charter)
Delaware
85-0558704
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
283 County Road 519
Belvidere, NJ 07823
(Address of principal executive offices) (Zip Code)
(908) 750-3953
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
EDBL
The Nasdaq Stock Market LLC
Warrants to purchase Common Stock
EDBLW
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large Accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes ☐ No ☒
As of November 4, 2026, the registrant had 504,135 shares of Common Stock, $0.0001 par value per share, outstanding.
PART I — FINANCIAL INFORMATION
Page
Item 1.
Financial Statements (Unaudited)
Condensed Consolidated Balance Sheets as of September 30, 2026 and December 31, 2025
3
Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025
4
Condensed Consolidated Statements of Stockholders' Equity (Deficit) for the Three and Nine Months Ended September 30, 2026 and 2025
5
Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025
6
Notes to Unaudited Condensed Consolidated Financial Statements
8
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
23
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
31
Item 4.
Controls and Procedures
PART II — OTHER INFORMATION
Legal Proceedings
32
Item 1A.
Risk Factors
Item 6.
Exhibits
33
Signatures
34
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per-share information)
September 30,
December 31,
2026
2025
ASSETS
Current assets:
Cash
Restricted cash, current
Accounts receivable, net
1,498
Inventory, net
Prepaid expenses and other current assets
Total current assets
10,148
Property, equipment and leasehold improvements, net
Operating lease right-of-use assets
Finance lease right-of-use assets
Intangible assets, net
Other assets
TOTAL ASSETS
24,369
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
LIABILITIES:
Current liabilities:
Accounts payable and other accrued expenses
Current maturities of operating lease liabilities
Current maturities of finance lease liabilities
Short-term debt, net of discounts
Derivative liability
Total current liabilities
Long-term liabilities:
Long-term debt, net of discounts
Long-term operating lease liabilities
Long-term finance lease liabilities
Total long-term liabilities
Total liabilities
COMMITMENTS AND CONTINGENCIES (Note 11)
STOCKHOLDERS’ EQUITY (DEFICIT):
Common stock ($0.0001 par value, 100,000,000 shares authorized; 462,212 and 2,637 shares outstanding as of September 30, 2026 and December 31, 2025, respectively (1))
Preferred stock ($1,000 par value, 10,000,000 shares authorized; 3,673 and 15,784 shares outstanding as of September 30, 2026 and December 31, 2025, respectively)
Additional paid-in capital
Obligation to issue shares
Accumulated deficit
Total stockholders’ equity (deficit)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
(1) Adjusted to reflect the stock splits as described in Note 1.
The accompanying notes are an integral part of the condensed consolidated financial statements.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
Nine Months Ended
REVENUE
OPERATING EXPENSES
Cost of goods sold, excluding depreciation
2,442
2,544
9,787
7,686
Selling, general and administrative expenses
Depreciation and amortization
Gain on sale of asset
Total operating expense
Loss from operations
Other income (expenses)
Interest expense, net
Loss on extinguishment of debt
Loss on sale of tax benefit
Gain on change in derivative liability
Other income / (loss)
Total other income (expenses)
)
Loss before income taxes
Income tax benefit
NET LOSS
Net loss per common share - basic and diluted (1)
Weighted-Average Number of Common Shares Outstanding – Basic and Diluted (1)
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (DEFICIT)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
(In thousands, except for shares) (1)
Common Stock
Preferred Stock
Additional
Paid-In
Obligation to Issue
Accumulated
Shares
Amount
Capital
Deficit
Total
Balance at June 30, 2026
Issuance of common stock and warrants in public offerings, net of expenses
Equity issuance costs
Accretion of preferred return on preferred stock
Series B preferred stock issued as payment of preferred return
Exchange of preferred for common stock
Acquisition related issuance of preferred shares
Reverse stock split adjustment, including rounding of fractional share
Net Loss
Balance at September 30, 2026
Balance at June 30, 2025
Reclassification of Series B preferred stock from temporary to permanent equity in connection with restated certificate of designation (Note 9)
Issuances of common stock for warrant exercises
Sale of common stock pursuant to Equity Distribution Agreement, net of fees
Accrued preferred return on preferred stock
Balance at September 30, 2025
The accompanying notes are an integral part of the condensed consolidated financial statements
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
Balance at December 31, 2025
Exchange of preferred stock for common stock
Issuance of common stock to employees and consultants
Balance at December 31, 2024
Issuances of common stock for services
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense
Amortization of operating lease right of use asset
Amortization of debt discount
(16
-
Stock-based compensation
Change in operating assets and liabilities:
Accounts receivable
646
Inventory
Accounts payable and accrued expenses
Operating lease liabilities
NET CASH USED IN OPERATING ACTIVITIES
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, equipment and leasehold improvements
Proceeds from sale of asset
NET CASH USED IN INVESTING ACTIVITIES
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from debt
Payments of debt principal
Proceeds from sale of preferred stock
Payment of commissions related to sale of common stock
(166
Proceeds from common stock and warrants issued in public offering
513
Proceeds from sales of common stock from Equity Distribution Agreement
Proceeds from common stock warrant exercises
Principal payments on finance lease liabilities
NET CASH PROVIDED BY FINANCING ACTIVITIES
NET CHANGE IN CASH AND RESTRICTED CASH
Cash and restricted cash at beginning of period
CASH AND RESTRICTED CASH AT END OF PERIOD
SUPPLEMENTAL DISCLOSURE FOR OPERATING ACTIVITIES:
Cash paid for interest
SUPPLEMENTAL DISCLOSURE FOR NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of preferred stock to settle preferred return payable
Obligation to issue preferred stock to settle preferred return payable
Discount on note payable related to embedded derivative
86
Reclassification of Series B preferred stock from temporary to permanent equity
Assets acquired through issuing preferred stock
Issuance of common stock for warrant exercise
Accrual of preferred return on preferred stock
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – ORGANIZATION, NATURE OF BUSINESS, AND BASIS OF PRESENTATION
Organization and Recent Developments
Edible Garden Corp., a Nevada corporation, was incorporated on April 9, 2013. On March 28, 2020, Edible Garden Inc., a Wyoming corporation, was incorporated for the purpose of acquiring substantially all of the operating assets of Edible Garden Corp., which was a separately identified reportable segment of its parent company Blum Holdings, Inc. (formerly known as Terra Tech Corporation). The acquisition was completed on March 30, 2020. Prior to March 30, 2020, Edible Garden AG Incorporated had no operations. Hereafter, Edible Garden AG Incorporated and its subsidiaries will collectively be referred to as “Edible Garden,” “we,” “us,” “our,” or the “Successor.” Edible Garden Corp., a wholly owned subsidiary of Blum Holdings, Inc. will be referred to as the “Predecessor.” Throughout these financial statements, the Successor and the Predecessor are also referred to as “the Company” and used interchangeably, unless otherwise noted. On October 1, 2024, the Company acquired the Predecessor for the nominal price of $1.00. See Note 10, “Leases” for additional information.
The Company authorized 100,000 shares of common stock, par value $0.0001 per share (“common stock”), at formation. On October 14, 2020, we simultaneously declared a 20-for-1 forward stock split of our common stock and increased the number of authorized common shares to 20,000,000. On June 30, 2021, we simultaneously (1) converted Edible Garden from a Wyoming corporation into a Delaware corporation, (2) declared a 1-for-2 reverse stock split of our common stock, and (3) increased the total number of authorized common shares to 50,000,000. On September 8, 2021, we simultaneously declared a 20-for-1 forward stock split of our common stock and increased the number of authorized common shares to 200,000,000. On January 18, 2022, the Company’s board of directors and stockholders approved a 1-for-5 reverse stock split of its outstanding common stock, which became effective on May 3, 2022. On January 26, 2023, we effected a reverse stock split of 1-for-30 and decreased the total number of authorized common shares to 6,666,667. On June 8, 2023, we increased the number of authorized shares of common stock from 6,666,667 shares to 10,000,000 shares.
On November 10, 2023, the Company increased the total number of authorized shares of capital stock of the Company from 20,000,000 to 110,000,000 and increased the total authorized shares of common stock from 10,000,000 shares to 100,000,000 shares. On April 5, 2024, the Company declared a 1-for-20 reverse stock split of our outstanding common stock, and on March 3, 2025, the Company declared a 1-for-25 reverse stock split of our outstanding common stock. On February 3, 2026, we declared a 1-for-10 reverse stock split of our outstanding common stock. Fractional shares resulting from the reverse stock split were rounded up to the next whole share, resulting in the issuance of approximately 114 additional shares of common stock.
On July 13, 2026, we declared a 1-for-45 reverse stock split of our outstanding common stock. The conversion or exercise prices of our issued and outstanding warrants were adjusted in connection with the reverse stock split. No fractional shares were issued in connection with the reverse stock split. Instead, stockholders who otherwise would have been entitled to receive a fractional share received a whole share through the rounding-up mechanism provided in the Certificate of Amendment. The reverse stock split did not affect the par value of the Company's common stock, which remains $0.0001 per share, or the number of authorized shares of common stock, which remains 100,000,000 shares.
On November 17, 2026, we declared a 1-for-5 reverse stock split of our outstanding common stock. The conversion or exercise prices of our issued and outstanding warrants were adjusted in connection with the reverse stock split. No fractional shares were issued in connection with the reverse stock split. Instead, stockholders who otherwise would have been entitled to receive a fractional share received a whole share through the rounding-up mechanism provided in the Certificate of Amendment. The reverse stock split did not affect the par value of the Company's common stock, which remains $0.0001 per share, or the number of authorized shares of common stock, which remains 100,000,000 shares. All historical share and per share amounts reflected throughout this report have been adjusted to reflect the stock splits described above.
Nature of Business
Edible Garden is a diversified clean-label nutrition company rooted in controlled environment agriculture (CEA). The Company produces and distributes locally grown, organic, and sustainable fresh produce and herbs, along with a growing portfolio of branded consumer packaged goods and nutraceutical products. The Company's products are available in more than 7,000 retail locations across the United States, the Caribbean, and South America, as well as through e-commerce channels. The Company is also developing its Prairie Hills facility in Webster City, Iowa into a ready-to-drink (“RTD”) clean nutrition manufacturing hub under its Farm-to-Formula strategy, which initiative is in the development stage and has not yet generated revenue. Our target customers are health-conscious individuals and families seeking fresh, locally grown produce and clean-label, better-for-you nutrition products.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. Therefore, these financial statements should be read in conjunction with our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed with the Securities and Exchange Commission (“SEC”) pursuant to Section 13 or 15(d) under the Securities Exchange Act of 1934. The December 31, 2025 balances reported herein are derived from the audited consolidated financial statements for the year ended December 31, 2025. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.
All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the Company’s unaudited condensed consolidated financial position as of September 30, 2026, the Company’s audited condensed consolidated financial position as of December 31, 2025, and the unaudited condensed consolidated results of operations for the three and nine months ended September 30, 2026 and 2025, and the unaudited condensed statement of cash flows for the nine months ended September 30, 2026 and 2025 have been included. Certain prior period amounts in cost of goods sold and selling, general, and administrative expenses have been reclassified to conform to current presentation.
Going Concern
The accompanying financial statements have been prepared assuming that we will continue as a going concern. In an effort to achieve liquidity that would be sufficient to meet all of our commitments, the Company may seek funding through additional debt or equity financing arrangements, implement incremental expense reduction measures or a combination thereof to continue financing its operations.
However, we believe that even after taking these actions, we will not have sufficient liquidity to satisfy all of our future financial obligations. The risks and uncertainties surrounding our ability to continue our business with limited capital resources indicate that substantial doubt exists as to our ability to continue as a going concern. See Note 13, “Going Concern” for additional information.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Recently Issued Accounting Pronouncements to Be Adopted in Future Periods
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures, as clarified by ASU 2025-01, which requires public business entities to disclose additional disaggregated information about certain income statement expense captions. The guidance is effective for annual periods beginning after December 15, 2026, and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this guidance on its financial statement disclosures.
Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if adopted, would have a material impact on the Company’s condensed consolidated financial statements or related disclosures.
Use of Estimates
The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reported period. Changes in these estimates and assumptions may have a material impact on the condensed consolidated financial statements and accompanying notes.
Examples of significant estimates and assumptions include allowance for credit losses, net realizable value of inventory, accrued liabilities, and discount rates used in the measurement and recognition of lease liabilities. These estimates generally involve complex issues and require us to make judgments, involving an analysis of historical and future trends, that can require extended periods of time to resolve, and are subject to change from period to period. In all cases, actual results could differ materially from our estimates.
Trade and Other Receivables
The Company extends non-interest-bearing trade credit to its customers in the ordinary course of business which is not collateralized. Accounts receivable are shown on the face of the consolidated balance sheets net of an allowance. The Company analyzes the aging of accounts receivable, historical bad debts, customer creditworthiness and current and expected future economic trends, in determining the allowance. The Company does not accrue interest receivable on past due accounts receivable. The reserve for credit losses was $170,445 and $413,483 as of September 30, 2026, and December 31, 2025, respectively.
Concentration of Credit Risk
During the nine months ended September 30, 2026 and 2025, five customers accounted for approximately 76.6% and four customers accounted for 81.9% of our total revenue, respectively. As of September 30, 2026, approximately 68.4% of our gross outstanding trade receivables were attributed to five customers. As of December 31, 2025, approximately 87.5% of our gross outstanding trade receivables were attributed to five customers, 45.6% of which was due from one customer.
This concentration of customers leaves us exposed to the risks associated with the loss of one or more of these significant customers, which would materially and adversely affect our revenues and results of operations.
Fair Value of Financial Instruments
The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.
The following are the hierarchical levels of inputs to measure fair value:
· Level 1 – Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
· Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
· Level 3 – Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.
The only financial instrument measured at fair value on a recurring basis is the embedded derivative, see Note 7, “Notes Payable”, for further disclosure.
We value our inventory at the lower of the actual cost of our inventory, as determined using the first-in, first-out method, or its net realizable value. We periodically review our physical inventory for excess, obsolete, and potentially impaired items and reserve accordingly. Our reserve estimate for excess and obsolete inventory is based on expected future use. Our reserve estimates have historically been consistent with our actual experience as evidenced by actual sale or disposal of the goods. The reserve for excess and obsolete inventory was not material as of September 30, 2026 and December 31, 2025.
Prepaid Expenses and Other Current Assets
Prepaid expenses consist of various payments that the Company has made in advance for goods or services to be received in the future. These prepaid expenses include advertising, insurance, and service or other contracts requiring up-front payments.
Property, Equipment and Leasehold Improvements, Net
Property, equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The Company’s leasehold improvements, equipment and vehicles, have useful lives of five years. Land has indefinite useful life, and construction in progress has no useful life until the asset is available for use.
Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. The Company continually monitors events and changes in circumstances that could indicate that the carrying balances of its property, equipment and leasehold improvements may not be recoverable in accordance with the provisions of Accounting Standards Codification ("ASC”) 360, “Property, Plant, and Equipment.” When such events or changes in circumstances are present, the Company assesses the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets. See Note 4, “Property, Equipment and Leasehold Improvements, Net” for further information.
Intangible Assets
Intangible assets continue to be subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined.
The Company reviews intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Conditions that may indicate impairment include, but are not limited to, a significant adverse change in legal factors or business climate that could affect the value of an asset, a product recall, or an adverse action or assessment by a regulator. If an impairment indicator exists, we test the intangible asset for recoverability. For purposes of the recoverability test, we group our amortizable intangible assets with other assets and liabilities at the lowest level of identifiable cash flows if the intangible asset does not generate cash flows independent of other assets and liabilities. If the carrying value of the intangible asset (asset group) exceeds the undiscounted cash flows expected to result from the use and eventual disposition of the intangible asset (asset group), the Company will write the carrying value down to the fair value in the period the impairment is identified.
Revenue Recognition and Performance Obligations
Revenues are recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company does not offer returns, discounts, loyalty programs or other sales incentive programs that are material to revenue recognition. Payments from our customers are due upon delivery or within a short period after delivery.
Disaggregation of Revenue
The following table includes revenue disaggregated by revenue stream for the three and nine months ended September 30, 2026 and 2025:
(in thousands)
Three Months Ended,
Nine Months Ended,
September 30, 2026
September 30, 2025
Herbs, Produce & Floral
2,934
Vitamins and Supplements
277
1,073
Contract Balances
Due to the nature of the Company’s revenue from contracts with customers, the Company does not have material contract assets or liabilities that fall under the scope of ASC Topic 606.
Contract Estimates and Judgments
On January 1, 2024, the Company and Meijer Distribution, Inc. (the “Buyer”) entered into two agreements pursuant to which the Company will supply and sell products to Buyer (the “Agreements”). Under the Agreements, the Company sells (i) fresh cut herbs, including basil, bay leaves, chives, cilantro, dill, mint, oregano, rosemary, sage, thyme; (ii) hydroponic basil; and (iii) potted herbs, including basil, chives, cilantro, mint, oregano, parsley, rosemary, sage, thyme, wheatgrass; in quantities and on a delivery schedule requested by the Buyer at prices per unit set in advance by the Company and the Buyer. Under the Agreements, the Company and the Buyer will renegotiate the prices for each unit annually, provided that the price per unit will not increase or decrease at a rate greater than the change in the relevant Consumer Price Index in that year. Once set, the pricing terms will remain fixed for the remainder of the year. Any price increases will take effect after sixty days and any price decrease will be effective immediately. If the Company and the Buyer are unable to mutually agree on price increases, the Company will have the power to terminate the Agreements immediately.
In addition, under the agreement governing the purchase of potted herbs, the Company agreed to fund the installation of fixtures in each of the Buyer’s stores to display the potted herbs in an aggregate amount estimated to be approximately $806,947. These payments are made as a weekly deduction from the Company’s receivables from the Buyer.
The Agreements became effective as of January 1, 2024 and expire on December 31, 2026. The Agreements may be renewed for an additional two-year term upon the mutual agreement of the Company and the Buyer. The Agreements may be terminated by the Buyer without cause upon sixty days’ prior notice.
Management has determined the payments for the fixtures should be treated as a reduction in revenue under the guidance of ASC 606. As we do not expect the agreement to be terminated before the end of the three-year term, the aggregate cost of the fixtures of approximately $806,947 was treated as a reduction in the transaction price of products sold to the Buyer during the three-year term of the contract.
On July 28, 2026, the Company and Buyer entered into a purchase agreement pursuant to which the Company will supply Buyer-branded products to the Buyer (the “2027 Agreement”) beginning in January 2027. The 2027 Agreement will replace the Agreements between the Company and the Buyer scheduled to expire December 31, 2026.
Cost of Goods Sold
Cost of goods sold includes materials, labor and overhead costs incurred in cultivating, producing, and shipping our products.
Advertising Expenses
The Company expenses advertising costs as incurred in accordance with ASC 720-35, “Other Expenses – Advertising Cost.” During the nine months ended September 30, 2026 and 2025, advertising expenses totaled $144,974 and $138,806, respectively.
Loss Per Common Share
In accordance with the provisions of ASC 260, “Earnings Per Share,” net loss per share is computed by dividing net loss by the weighted-average shares of common stock outstanding during the period. During a loss period, the effect of the potential exercise of stock options, warrants, convertible preferred stock, and convertible debt are not considered in the diluted loss per share calculation since the effect would be anti-dilutive. The results of operations were a net loss for the nine months ended September 30, 2026 and 2025. Therefore, the basic and diluted weighted-average shares of common stock outstanding were the same for all periods. Diluted earnings per share for the three and nine months ended September 30, 2026 and 2025 excluded warrants to purchase 1,962 and 1,220 shares of common stock, respectively, because their effects were anti-dilutive.
Numerator:
Accretion of Series B preferred stock
(45
(305
(454
Deemed dividend on warrants
Net loss attributable to common stockholders – basic and diluted
Denominator:
Weighted average shares outstanding – basic and diluted
Net loss per share:
Income Taxes
The provision for income taxes is determined in accordance with ASC 740, “Income Taxes”. The Company files a consolidated United States federal income tax return. The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expense are expected to be settled in our income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred income taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating losses for financial-reporting and tax-reporting purposes. At September 30, 2026 and December 31, 2025, such net operating losses were offset entirely by a valuation allowance.
The Company recognizes uncertain tax positions based on a benefit recognition model. Provided that the tax position is deemed more likely than not of being sustained, the Company recognizes the largest amount of tax benefit that is greater than 50.0% likely of being ultimately realized upon settlement. The tax position is derecognized when it is no longer more likely than not of being sustained. The Company classifies income tax related interest and penalties as interest expense and selling, general and administrative expense, respectively, on the condensed consolidated statements of operations.
During the nine months ended September 30, 2026, the Company completed a transaction under the New Jersey Technology Business Tax Certificate Transfer Program administered by the New Jersey Economic Development Authority, pursuant to which the Company sold certain unused New Jersey state net operating loss carryforwards (collectively, the “Tax Benefits”) to an unrelated third party.
Under the terms of the agreement, the Company transferred the Tax Benefits with a face value of approximately $3.4 million in exchange for gross proceeds of approximately $3.1 million, resulting in net cash proceeds of approximately $3.0 million after transaction-related costs of approximately $0.1 million.
Segment Reporting
The Company is not organized by multiple operating segments for the purpose of making operating decisions or assessing performance. Accordingly, the Company operates in one operating segment. The Company’s chief operating decision maker (“CODM”) consists of the Chief Executive Officer and its Chief Financial Officer. Management believes that its business operates as one segment because: a) CODM evaluates profit and loss of the Company as a whole; b) the CODM does not review information based on any operating segment; c) the Company does not maintain discrete financial information on any specific segment; d) the Company has not chosen to organize its business around different products and services, and e) the Company has not chosen to organize its business around geographic areas. Accordingly, all amounts required to be disclosed under ASC 280 are included in the financial statements. The measure of segment profit/loss, measure of segment assets, and significant segment expenses that are regularly provided to the chief operating decision maker are shown individually in the statements of operations and balance sheets
NOTE 3 – SELECTED CURRENT ASSET ACCOUNTS
The following table summarizes prepaid expenses and other current assets as of September 30, 2026 and December 31, 2025:
Prepaid insurance
Other prepaid expenses
Vendor prepayment
Total prepaid expenses and other current assets
The following table summarizes inventory as of September 30, 2026 and December 31, 2025:
Raw materials
Work-in-progress
Finished goods
Total inventory
NOTE 4 – PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS, NET
The following table summarizes property, equipment and leasehold improvements as of September 30, 2026 and December 31, 2025:
Furniture and equipment
Computer hardware
Leasehold improvements
Vehicles
Land
Construction in progress
Subtotal
Less accumulated depreciation
Depreciation expense related to property, equipment and leasehold improvements for the nine months ended September 30, 2026 and 2025 was $3,975,693 and $1,223,348, respectively. Depreciation of certain fixed assets was accelerated in the nine months ended September 30, 2026 as a result of the Company's pivot to RTD clean nutrition manufacturing.
NOTE 5 – INTANGIBLE ASSETS
The following table summarizes intangible assets as of September 30, 2026 and December 31, 2025:
Estimated
December 31, 2025
Useful
Life in
Years
Gross
Carrying
Value
Accumulated Amortization
Net
Carrying Value
Amortizing Intangible Assets:
Intellectual property
15
Pulp brand recipes
Non-compete agreement
2
Total Intangible Assets, net
Amortization expense for the nine months ended September 30, 2026 and 2025 was $16,224 and $10,125, respectively. Annual amortization expense for each of the next five years is estimated to be $21,632 and thereafter $176,098.
NOTE 6 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES
The following table summarizes accounts payable and accrued expenses as of September 30, 2026 and December 31, 2025:
Accounts payable
Accrued interest payable
Accrued payroll
Accrued vacation
Other accrued expenses
Employee retention credit funds
Total Accounts Payable and Accrued Expenses
NOTE 7 – NOTES PAYABLE
The following table summarizes notes payable as of September 30, 2026 and December 31, 2025:
Streeterville note
Avondale secured promissory note
Insurance financing agreement
NJD Investments, LLC promissory note
SBA loans
Vehicle loans
Total Gross Debt
Less: debt discounts and issuance costs
Total Net Debt
The principal payments due on our notes payable for the remaining three months ending December 31, 2026 and for each of the next four years ending December 31, and thereafter were as follows (in thousands):
Years Ending December 31,
2026 (remaining)
2027
2028
2029
2030
Thereafter
Streeterville Note
On March 3, 2026, the Company entered into a Note Purchase Agreement (the “NP Agreement”) with Streeterville Capital, LLC (“Streeterville”), pursuant to which the Company issued a secured promissory note (the “Streeterville Note”) with an aggregate principal balance of $1,625,000. The Streeterville Note included an original issue discount (“OID”) of $120,000 and reimbursement of transaction expenses of $5,000, resulting in net cash proceeds to the Company of approximately $1.5 million.
The Streeterville Note bears interest at a rate of 8.0% per annum and matures 13 months from the issuance date. Beginning six months following issuance, Streeterville may redeem portions of the outstanding balance, subject to the terms and conditions of the Streeterville Note, in amounts not to exceed $50,000 per month.
In addition, beginning three months after issuance of the Streeterville Note, the Company is required to pay a monthly monitoring fee to Streeterville in accordance with the terms of the NP Agreement. The monitoring fee is recorded within interest expense over the term in which the obligation is incurred.
The Streeterville Note is secured by substantially all of the Company’s assets pursuant to a related security agreement. The obligations under the Streeterville Note contain customary events of default, including, among others, failure to make required payments, bankruptcy or insolvency events, and breaches of representations, warranties or covenants. Upon an event of default, the outstanding obligations may become immediately due and payable and may accrue interest at a default rate as defined in the agreement.
The Company evaluated the accounting treatment of the Streeterville Note under applicable accounting guidance, including ASC 470, Debt, and ASC 815, Derivatives and Hedging. The Company concluded that the OID and debt issuance costs should be recorded as a direct deduction from the carrying amount of the debt and amortized to interest expense over the term of the Streeterville Note using the effective interest method and that certain contingent payment provisions, including the monitoring fee and trigger effect provisions, could result in additional amounts becoming payable upon the occurrence or nonoccurrence of specified future events. The Company determined that these features were not clearly and closely related to the debt host and therefore were required to be bifurcated and accounted for separately as an embedded derivative liability. The fair value of the embedded derivative was determined using a probability-weighted valuation methodology that considered the expected incremental cash flows associated with the monitoring fee and trigger effects, including the probability of the applicable events and an appropriate discount rate. The embedded derivative was initially recognized at fair value as a debt discount and is subsequently remeasured at fair value at each reporting date, with changes in fair value recognized in earnings
Streeterville Notes A-1 and B
On June 12, 2026, the Company entered into a Notes Purchase Agreement with Streeterville pursuant to which it issued (i) a Promissory Note A-1 with an original principal amount of $2.17 million (the “A-1 Note”)and (ii) a Secured Promissory Note B with an original principal amount of $10.0 million (the “B Note” and, together with the A-1 Note, the “Notes”). The Notes mature eighteen months from issuance. The A-1 Note bears interest at 8% per annum, while the B Note bears interest at 5% per annum. Interest compounds daily based on a 360-day year.
The Company received aggregate financing proceeds of $12.0 million. Of this amount, $2.0 million was funded directly to the Company. The remaining $10.0 million was deposited into a restricted deposit account maintained pursuant to a Deposit Account Control Agreement. The funds remain restricted and serve as collateral for the B Note until released in accordance with the terms of the financing agreements.
Under the Notes Purchase Agreement, each time the aggregate stated value of the Company’s Series B Preferred Stock held by Streeterville that is retired reaches $500,000, the Company is entitled to request an exchange of $250,000 of the B Note for an A-1 Note. Upon completion of such exchange, an amount equal to the portion of the outstanding balance of the B Note exchanged is released from the restricted deposit account. If the Company does not request the exchange within the applicable 60-day period, the exchange occurs automatically on the 61st day following the applicable event.
As of September 30, 2026, the Company had 3,673 shares of Series B Preferred Stock outstanding. The Company classified the full balance of the Deposit Account Control Agreement (“DACA”) account, $4.4 million, as restricted cash expected to be released within twelve months of the balance sheet date based on dual signed agreements to release funds or anticipated reductions in the aggregate stated value of the Series B Preferred Stock as current restricted cash.
The A-1 Note includes an original issue discount of $160,000 and a $10,000 transaction expense payable to the lender, both of which are included in the initial principal amount of the note and are being amortized as additional interest expense over the term of the borrowing using the effective interest method.
The B Note is secured by the restricted deposit account, a first-priority security interest in the membership interests of EDBL Holdings, LLC, and guarantees provided by certain wholly owned subsidiaries. Beginning six months after issuance, the lender may require monthly cash redemptions of portions of the A-1 Note and, under specified circumstances, limited redemptions of the B Note. The financing documents also permit exchanges of portions of the B Note into additional A Notes upon the occurrence of specified contractual milestones. The Company will evaluate any future exchanges under the debt modification and extinguishment guidance in ASC 470-50 when such exchanges occur.
NOTE 8 – SERIES B PREFERRED STOCK
In connection with the asset purchase agreement (the “APA”), on May 13, 2025, the Board approved a certificate of designation, subsequently amended on July 29, 2025 and August 13, 2025, fixing the voting powers, designations, preferences and rights and the qualifications, limitations or restrictions of the Series B Preferred Stock, a series of preferred stock of the Company. Of the Company’s 10,000,000 previously undesignated shares of preferred stock, 50,000 shares were designated as Series B Preferred Stock as of May 14, 2025.
As consideration for the acquired assets pursuant to the APA, the Company issued 12,000 shares of Series B Preferred Stock to Streeterville as the sole shareholder of NaturalShrimp, at a stated value of $1,000 per share, for an aggregate purchase price of $12,000,000.
Also on May 14, 2025, the Company entered into a stock purchase agreement (the “SPA”) with Streeterville, pursuant to which the Company issued 3,000 shares of Series B Preferred Stock, at a stated value of $1,000 per share, to Streeterville, for the purchase price of $3,000,000. Additionally, pursuant to the SPA, Streeterville purchased an additional 500 shares of Series B Preferred Stock, at a stated value of $1,000 per share, on November 14, 2025 for a purchase price of $500,000. The SPA contains customary representations and warranties, covenants and agreements of the Company and Streeterville. The shares of Series B Preferred Stock were issued and sold to Streeterville without registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemption provided by Section 4(a)(2) of the Securities Act as a transaction not involving a public offering.
On September 30, 2026, the Company entered into a Real Estate Purchase Contract (the “Purchase Contract”) with Iowa Shrimp Holdings, LLC, an Iowa limited liability company (the “Seller”), pursuant to which the Company agreed to purchase from the Seller the Company’s Prairie Hills Facility in Webster, Iowa.
The aggregate purchase price for the Property is $6,325,000 (the “Purchase Price”). At the direction of the Seller, the Purchase Price was paid to Streeterville as follows: (i) on September 30, 2026, the Company issued to Streeterville 1,500 shares of the Company’s Series B Preferred Stock (the “Initial Preferred Shares”), which the parties assigned an agreed value of $1,500,000 and which are non-refundable; (ii) at the closing of the acquisition contemplated by the Purchase Contract (the “Closing”), the Company issued to Streeterville an additional 1,000 shares of the Company’s Series B Preferred Stock, which the parties assigned an agreed value of $1,000,000 (the “Closing Preferred Shares”); and (iii) at the Closing, the Company issued to Streeterville a secured promissory note in the original principal amount of $3,825,000 (the “Note”). The Note will mature five years after its date of issuance and will bear interest at a rate of 8% per annum, compounded daily. The Company’s obligations under the Note will be secured by a real estate mortgage on the Property in favor of Streeterville (the “New Mortgage”).
Beginning in December 2025, the Company entered into a series of exchange agreements with Streeterville pursuant to which shares of Series B Preferred Stock were exchanged for shares of the Company's common stock. As of December 31, 2025, the Company had exchanged 175 shares of Series B Preferred Stock for an aggregate of 2,892 shares of common stock, with the aggregate stated value of the exchanged preferred shares totaling $175,000. For the nine months ended September 30, 2026, the Company exchanged 14,331 shares of Series B Preferred Stock for an aggregate of 388,980 shares of common stock, with the aggregate stated value of the exchanged preferred shares totaling $14,331,000.
As of September 30, 2026, there were 3,673 shares of Series B Preferred Stock outstanding.
NOTE 9 – STOCKHOLDERS’ EQUITY (DEFICIT) AND STOCK-BASED COMPENSATION
Public Offerings
On May 23, 2024, the Company completed a best-efforts public offering (the “May Offering”) of (i) 1,084 common units, each consisting of one share of common stock, one Class A warrant (“May Class A Warrant”) to purchase one share of common stock and one Class B warrant (“May Class B Warrant,” together with the May Class A Warrants, the “May Warrants”) to purchase one share of common stock at a purchase price of $127,125 per unit; and (ii) 4 pre-funded units, each consisting of one pre-funded warrant to purchase one share of common stock (“May Pre-Funded Warrant”), one May Class A Warrant and one May Class B Warrant at a purchase price of $126,675 per unit.
The May Warrants had an exercise price of $127,125 per share, subject to an exercise price reset, were immediately exercisable, and, in the case of May Class A Warrants, will expire on May 23, 2029, and in the case of May Class B Warrants, will expire on November 23, 2025. The May Warrants had an exercise price reset feature whereby if, on June 22, 2024, the exercise price of the May Warrants was greater than the arithmetic average of the volume-weighted average price of the common stock for the prior five days (the “reset price”), the exercise price of the May Warrants would be reduced to the reset price. Pursuant to the reset feature, the exercise price of the May Warrants became $83,815 on June 22, 2024. The exercise price of the May Warrants is also subject to adjustment for stock splits, reverse splits, and similar capital transactions as described in such May Warrants.
Subject to certain ownership limitations described in the May Pre-Funded Warrants, the May Pre-Funded Warrants were immediately exercisable and may be exercised at a nominal exercise price of $565 per share of common stock any time until all of the May Pre-Funded Warrants are exercised in full.
In connection with the May Offering, on May 22, 2024, the Company also entered into a placement agency agreement pursuant to which Maxim Group LLC (“Maxim”) served as the exclusive placement agent in connection with the May Offering. The Company paid Maxim a cash fee of 7.0% of the aggregate gross proceeds raised at the closing of the May Offering and reimbursement of certain expenses and legal fees in the amount of $80,000. The Company also issued Maxim warrants to purchase up to an aggregate of 24 shares of common stock (the “May Placement Agent Warrants”). The May Placement Agent Warrants have an exercise price of $127,125 per share and have substantially the same terms as the May Class A Warrants, except the May Placement Agent Warrants were not subject to an exercise price reset and were exercisable beginning November 18, 2024.
The Company received gross proceeds of $5,998,120 from the May Offering and paid underwriting fees of $499,868, resulting in net proceeds of $5,498,252.
On September 30, 2024, the Company closed a best-efforts public offering (the “September Offering”) of (i) 76 common units, each consisting of one share of common stock, one Class A warrant (the “September Class A Warrant”) to purchase one share of common stock and one Class B warrant (the “September Class B Warrant,” together with the September Class A Warrants, the “September Warrants”) to purchase one share of common stock at a purchase price of $20,250 per unit; and (ii) 204 pre-funded units, each consisting of one pre-funded warrant to purchase one share of common stock (“September Pre-Funded Warrant”), one September Class A Warrant and one September Class B Warrant at a purchase price of $19,690 per unit.
The September Warrants have an exercise price of $20,250 per share, are immediately exercisable, and, in the case of September Class A Warrants, will expire on September 30, 2029, and in the case of September Class B Warrants, will expire on March 30, 2026. The exercise price of the September Warrants is subject to adjustment for stock splits, reverse splits, and similar capital transactions as described in such September Warrants. Subject to certain ownership limitations described in the September Pre-Funded Warrants, the September Pre-Funded Warrants are immediately exercisable and may be exercised at a nominal exercise price of $25,425 per share of common stock any time until all of the September Pre-Funded Warrants are exercised in full.
Inducement Letters
On December 23, 2024, the Company entered into an inducement letter agreement (the “December 2024 Inducement”) with an institutional investor and existing holder (the “Holder”) of September Class B Warrants to purchase 148 shares of the Company’s common stock. Pursuant to the December 2024 Inducement, the Holder agreed to exercise the September Class B Warrants for cash at the exercise price of $20,250 per share in consideration for the Company’s agreement to issue: (i) new unregistered five-year warrants to purchase up to an aggregate of 148 shares of common stock at an exercise price of $20,250 per share (the “December 2024 Class A Warrants”), and (ii) new unregistered eighteen-month warrants to purchase up to an aggregate of 148 shares of common stock at an exercise price of $20,250 per share (the “December 2024 Class B Warrants”). The December 2024 Class A Warrants were immediately exercisable upon issuance and have a term of five years from the issuance date, and the December 2024 Class B Warrants were immediately exercisable and have a term of eighteen months from the issuance date. The Company received $3,841,000 of proceeds from the Inducement Letter Agreement and recognized $177,308 for underwriting and other fees as of December 31, 2024. As a result of the December 2024 Inducement, the Company recognized a deemed dividend of $3,873,000 during the year ended December 31, 2024.
On May 21, 2025, the Company entered into an inducement letter agreement (the “May 2025 Inducement”) with the Holder of September Class A Warrants to purchase 148 shares of the Company’s common stock, (ii) December 2024 Class A Warrants to purchase 740 shares of Common Stock and (iii) December 2024 Class B Warrants to purchase 148 shares of Common Stock; and collectively, the (“Existing Warrants”). The Existing Warrants had original exercise prices of $20,250 per share and became exercisable immediately following issuance. Pursuant to the May 2025 Inducement, the Holder agreed to exercise the Existing Warrants for cash at a reduced exercise price of $7,875 per share in consideration for the Company’s agreement to issue new unregistered five-year warrants to purchase up to an aggregate of 889 shares of Common Stock at an exercise price of $7,875 per share (the “May 2025 Warrants”). The May 2025 Warrants were immediately exercisable upon issuance and have a term of five years from the initial exercise date. The Company received $3,498,000 of gross proceeds from the May 2025 Inducement and recognized $237,000 for underwriting and other fees as of June 30, 2025. As a result of the May 2025 Inducement, the Company recognized a deemed dividend of $9,833,000.
On October 16, 2025, the Company entered into an inducement letter agreement (the “October 2025 Inducement”) with an institutional investor and existing holder of (i) warrants to purchase 1 shares of the Company’s common stock issued on May 9, 2022 with an initial exercise price of $375,000 (the “May 2022 Warrants”), (ii) warrants to purchase 1 shares of Common Stock issued on September 8, 2023 with an initial exercise price of $1,350,000 (the “September 2023 Warrants”), (iii) Class A warrants to purchase 5 shares of Common Stock and Class B warrants to purchase 48 shares of Common Stock issued on May 23, 2024 with initial exercise prices of $83,813 (the “May 2024 Warrants”), and (iv) warrants to purchase 889 shares of Common Stock issued on May 21, 2025 with an initial exercise price of $7,875 (the “May 2025 Warrants” and collectively with the May 2022 Warrants, September 2023 Warrants, and May 2024 Warrants, the “Existing Warrants”). The Existing Warrants were all immediately exercisable upon issuance. Pursuant to the October 2025 Inducement, the Holder agreed to exercise the Existing Warrants for cash at a reduced exercise price of $4,635 per share in consideration for the Company’s agreement to issue new unregistered five-year warrants to purchase up to an aggregate of 1,797 shares of Common Stock at an exercise price of $4,635 per share (the “October 2025 Warrants”). The October 2025 Warrants will be immediately exercisable upon issuance and have a term of five years from the initial exercise date. The Company received $4,164,000 of gross proceeds from the October 2025 inducement and recognized $280,000 for underwriting and other fees as of December 31, 2025. As a result of the October 2025 Inducement, the Company recognized a deemed dividend of $6,685,000.
Equity Distribution Agreement
On January 31, 2025, the Company entered into an Equity Distribution Agreement (the “2025 EDA”) with Maxim as sales agent, pursuant to which the Company sold shares of its common stock through Maxim in an at-the-market offering for an aggregate offering price of up to $2,516,000. Under the terms of the 2025 EDA, Maxim sold the shares at market prices by any method that is deemed to be an “at-the-market offering” as defined in Rule 415 under the Securities Act. The offering of shares of our common stock pursuant to the 2025 EDA terminated on January 31, 2026.
Subject to the terms and conditions of the 2025 EDA, Maxim used its commercially reasonable efforts to sell shares of common stock from time to time, based upon the Company’s instructions. The Company has provided Maxim with customary indemnification rights, and Maxim will be entitled to a fixed commission of 3.5% of the aggregate gross proceeds from the shares sold. The Company agreed to reimburse Maxim for the fees and disbursements of its counsel, payable upon execution of the 2025 EDA, in an amount not to exceed $30,000 in connection with the establishment of this at-the-market offering program, in addition to certain ongoing fees of its legal counsel.
During the year ended December 31, 2025, we sold 343 shares of common stock for total gross proceeds of $2,428,392 and paid commissions to Maxim of $88,000.
On August 11, 2026, the Company entered into an Equity Distribution Agreement (the “2026 EDA”) with Maxim as sales agent, pursuant to which the Company may, from time to time, issue and sell shares of its common stock through Maxim in an at-the-market offering for an aggregate offering price of up to $7,195,548. Under the terms of the 2026 EDA, Maxim may sell the shares at market prices by any method that is deemed to be an “at-the-market offering” as defined in Rule 415 under the Securities Act. The offering of shares of our common stock pursuant to the 2026 EDA will terminate upon the earliest of (i) August 11, 2027, (ii) the sale of all Shares provided for in the prospectus supplement related to this offering, and (iii) the termination of the EDA by written notice of the Company or Maxim.
The Company has authorized 100,000,000 shares of common stock with $0.0001 par value.
Stock-Based Compensation
On January 18, 2022 in connection with the IPO, the board of directors (the “Board”) approved the Edible Garden AG Incorporated 2022 Equity Incentive Plan (the “2022 Plan”). The 2022 Plan provides for equity incentive compensation for employees, non-employee directors, and any other individuals who perform services for the Company. The number of shares initially available for grant under the 2022 Plan was 20. A variety of discretionary awards are authorized under the 2022 Plan, including stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. The vesting of such awards may be conditioned upon either a specified period of time or the attainment of specific performance goals as determined by the administrator of the 2022 Plan. The option price and terms are also subject to determination by the administrator with respect to each grant.
On June 8, 2023 the stockholders of the Company approved the First Amendment to the 2022 Plan, which increased the number of shares of common stock reserved for issuance thereunder by 3 shares and extended the term of the 2022 Plan until June 8, 2033.
On August 21, 2024, the stockholders of the Company approved the Second Amendment to the 2022 Plan to: (i) increase the number of shares of common stock reserved for issuance thereunder by 116 shares, (ii) update the recoupment provisions of the 2022 Plan to be consistent with the Company’s Policy for the Recovery of Erroneously Awarded Compensation, and (iii) extend the term of the 2022 Plan until August 21, 2034.
On September 24, 2025, the stockholders of the Company approved the Amended and Restated 2022 Plan (the “A&R 2022 Plan”) to: (i) increase the number of shares of common stock reserved for issuance thereunder by 4,445 shares; (ii) provide that non-employee directors and officers of the Company and its affiliates (“Members of Management”) are ineligible to receive new awards under the 2022 Plan; (iii) add an “evergreen” provision that will allow for an annual increase in the number of shares available for issuance under the A&R 2022 Plan to be added on the first day of each calendar year starting January 1, 2026 and ending on January 1, 2035 in an amount up to 5% of the total number of shares of common stock outstanding on December 31 of the prior calendar year; and (iv) extend the term of the A&R 2022 Plan until September 24, 2035.
During the nine months ended September 30, 2026, under the A&R 2022 Plan, the Company issued 24 restricted stock awards to an employee of the Company as compensation and recognized stock-based compensation expense of $5,016 for the awards, which vested immediately. During the nine months ended September 30, 2025, the Company did not issue restricted stock awards.
As of September 30, 2026, shares available for future stock compensation grants, under the A&R 2022 Plan totaled 214.
On September 24, 2025, the stockholders of the Company approved the Company’s 2025 Officer and Director Equity Incentive Plan (the “2025 Plan”). The 2025 Plan differs from the A&R 2022 Plan in the following ways:
• Only Members of Management are eligible to receive awards under the 2025 Plan;
• on and after September 25, 2025, the Board will have all the powers otherwise vested in the Compensation Committee of the Board under the 2025 Plan instead of the 2022 Plan in respect of awards granted to non-employee directors; and
• the prior annual limitation on non-employee director awards is now in the 2025 Plan instead of A&R 2022 Plan, but the limit has not changed.
During the nine months ended September 30, 2026, under the 2025 Plan, the Company did not issue any restricted stock awards.
As of September 30, 2026, shares available for future stock compensation grants under the 2025 Plan totaled 3,457.
Warrants
There was no warrant activity during the nine months ended September 30, 2026. Total shares of common stock issuable upon exercise of the outstanding warrants is 1,962 as of September 30, 2026 and December 31, 2025 at a weighted-average exercise price per share of $9,615.
NOTE 10 – LEASES
Management determines if a contract is or contains a lease at inception or modification of a contract. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period in exchange for consideration. Control over the use of the identified asset means the lessee has both (a) the right to obtain substantially all of the economic benefits from the use of the asset and (b) the right to direct the use of the asset. Such assets are classified as right-of-use assets (“lease assets”) with a corresponding lease liability.
Finance and operating lease assets and liabilities are recorded at commencement at the present value of future minimum lease payments over the expected lease term. As the implicit discount rate for the present value calculation is not determinable in most of the Company’s leases, management uses the Company’s incremental borrowing rate based on the information available at commencement of the lease. The expected lease terms include options to extend the lease when it is reasonably certain the Company will exercise such options. Lease expense for minimum lease payments is recognized on a straight-line basis over the expected lease term. Leases with an expected term of 12 months or less are not accounted for on the balance sheet and the related lease expense is recognized on a straight-line basis over the expected lease term.
Operating Lease
On October 1, 2024, the Company acquired Edible Garden Corp. (“EGC”) from Unrivaled Brands, Inc., our former parent company, for the nominal price of $1.00. At our inception, the Company acquired substantially all of the assets of EGC from Unrivaled Brands, Inc., except for the lease agreement between EGC and Whitetown Realty, LLC (the “Landlord”), made as of December 30, 2014 (the “Lease Agreement”), as amended by a lease extension agreement between EGC and the Landlord dated September 10, 2019 (the “Lease Extension,” together with the Lease Agreement, the “Lease”), for a 5-acre greenhouse location in Belvidere, New Jersey. As a result, prior to October 1, 2024, we operated the New Jersey property through an informal arrangement with EGC in which the Company effectively rented the property on a month-to-month basis with no set term. On October 1, 2024, upon the closing of the acquisition of EGC, we assumed the Lease and became subject to its terms. The Lease has a term that commenced on January 1, 2015 and ends on December 31, 2029. Under the terms of the Lease, the Company will pay the Landlord a monthly lease payment of approximately $22,000 in 2025.
During the nine months ended September 30, 2026, total operating lease cost was $947,756 of which $23,695 was associated with short-term leases. During the nine months ended September 30, 2025, total operating lease cost was $614,078, of which $409,713 was associated with short-term leases.
The table below presents total operating lease assets and lease liabilities as of September 30, 2026 and December 31, 2025:
Operating lease assets
The table below presents the maturities of operating liabilities for the remaining three months ending December 31, 2026 and for each of the next four years ending December 31, and thereafter are as follows:
Operating
Leases
Total lease payments
Less: discount
Total operating lease liabilities
Other information related to the operating lease term and discount rate is as follows:
Weighted-average remaining lease term (years)
Interest rate
Finance Leases
The Company has finance leases for various vehicles with terms of approximately 3 years. The Company’s finance lease agreements do not contain any material non-lease components, residual value guarantees, or material restrictive covenants.
The table below presents total finance lease assets and lease liabilities as of September 30, 2026 and December 31, 2025:
Financing lease assets
The components of finance lease expense are as follows:
Classification on the Statement of Operations
Finance lease cost:
Amortization of right-of-use assets
Interest on finance lease liabilities
Total finance lease cost
The table below presents the maturities of financing lease liabilities for the remaining three months ending December 31, 2026 and for each of the next two years ending December 31, and thereafter were as follows:
Financing
Less: interest
Total finance lease liabilities
NOTE 11 – COMMITMENTS AND CONTINGENCIES
From time to time, we may be party to or otherwise involved in legal proceedings arising in the ordinary course of business. Management does not believe that there is any pending or threatened proceeding against us, which, if determined adversely, would have a material adverse effect on our business, results of operations or financial condition.
NOTE 12 – RELATED PARTY TRANSACTION
Streeterville is a principal stockholder of the Company and the sole holder of the Company's Series B Preferred Stock. Avondale Capital LLC (“Avondale”) is an affiliate of Streeterville. Both entities are considered related parties of the Company. During the nine months ended September 30, 2026, the Company entered into notes purchase agreements and related guarantees (see Note 7) and a series of Series B Preferred Stock exchange agreements (see Note 8) with Streeterville. As of September 30, 2026, the Company has an outstanding balance of notes payable due to Streeterville (see Note 7). See Notes 8 and 14 for more information about the Company’s purchase of the Prairie Hills Facility and related transactions with Streeterville.
NOTE 13 – GOING CONCERN
These financial statements are prepared on a going concern basis. The Company began operating in 2020. For the nine months ended September 30, 2026, we incurred a net loss of $9.4 million. We expect to experience further significant net losses in the foreseeable future. During the nine months ended September 30, 2026, the Company had operating cash flows of ($3.8) million. We have not been able to generate sufficient cash from operating activities to fund our ongoing operations. Since our inception, we have raised capital through our issuance of debt and equity securities. Our future success is dependent upon our ability to achieve profitable operations and generate cash from operating activities. There is no guarantee that we will be able to generate enough revenue and/or raise capital to support our operations.
We will be required to raise additional funds through public or private financing, additional collaborative relationships or other arrangements until we are able to raise revenue and reduce costs to a point of positive cash flow. We are evaluating various options to further reduce our cash requirements to operate at a reduced rate, as well as options to raise additional funds, including obtaining loans and selling securities. There is no guarantee that we will be able to generate enough revenue and/or raise capital to support our operations, or if we are able to raise capital, that it will be available to us on acceptable terms, on an acceptable schedule, or at all.
The issuance of additional securities may result in a significant dilution in the equity interests of our current stockholders. Obtaining loans, assuming these loans would be available, will increase our liabilities and future cash commitments. There is no assurance that we will be able to obtain further funds required for our continued operations or that additional financing will be available for use when needed or, if available, that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will not be able to meet our other obligations as they become due and we will be forced to scale down or perhaps even cease our operations.
The risks and uncertainties surrounding our ability to raise capital and to continue our business with limited capital resources indicates that substantial doubt exists as to our ability to continue as a going concern for twelve months from the issuance of these financial statements.
NOTE 14 – SUBSEQUENT EVENTS
On October 16, 2026, the Company entered into a Produce Supply Agreement (the “Supply Agreement”) with Caney Fork Farms, LLC (the “Supplier”), effective as of October 15, 2026, pursuant to which the Company agreed to the general terms and conditions of purchasing certain fresh produce for its core herb business (the “Products”) from the Supplier and reselling, distributing and/or further processing the Products for sale to the Company’s customers. Under the Supply Agreement, the Company and the Supplier agreed to fixed pricing for Products through January 31, 2027. Thereafter, the parties will mutually agree to any annual price changes, provided that no annual price increase will exceed the lesser of (i) the percentage increase in the published Producer Price Index applicable to the Products or (ii) 10%. During the term of the Supply Agreement, the Company has a right of first offer regarding any proposed opportunities of the Supplier to commercialize, market, sell or supply fresh-cut herbs, potted herbs or hydro basil, upon which the parties shall negotiate in good faith regarding such items. The right of first offer applies to all of the Supplier’s opportunities to grow, source, process, manufacture, package, market, distribute, license, commercialize, or sell any Products or other fresh-cut herbs not currently covered by the Supply Agreement. The Supply Agreement remains in effect until October 15, 2028 and automatically renews for successive one year terms unless either party provides written notice of non-renewal at least 60 days prior to expiration. The Company may immediately terminate the Supply Agreement if the Supplier fails to meet food safety or performance standards under the Supply Agreement. Either party may terminate the Supply Agreement for cause after a 30-day cure period for resolving a breach of the agreement. After October 15, 2028, either party may terminate the Supply Agreement without cause upon 120 days’ prior written notice.
As discussed in Note 8, the Company entered into a Purchase Contract with Iowa Shrimp Holdings, LLC, (the “Seller”), pursuant to which the Company agreed to purchase from the Seller the Company’s Prairie Hills Facility in Webster, Iowa. On October 30, 2026, pursuant to the Purchase Contract, the Company completed the acquisition of the Property (the “Closing”). At the Closing, the Seller conveyed the Property to Edible Garden Prairie Hills LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“Prairie Hills”). At the direction of the Seller, the Company issued to Streeterville 1,000 shares of the Company’s Series B Preferred Stock, which the parties assigned an agreed value of $1,000,000, and the Company issued to Streeterville a secured promissory note in the original principal amount of $3,825,000 (the “Note”). The Note matures five years after the date of issuance and bears interest at a rate of 8% per annum, compounded daily. The Company’s obligations under the Note are secured by a real estate mortgage on the Property granted by Prairie Hills in favor of Streeterville (the “Mortgage”). Together with the 1,500 shares of Series B Preferred Stock previously issued by the Company to Streeterville on September 30, 2026, which the parties assigned an agreed value of $1,500,000, the aggregate purchase price for the Property was $6,325,000.
On November 3, 2026, the Company exchanged 112 shares of Series B Preferred Stock with an aggregate stated value of $112,000 for a total 32,138 shares of common stock with Streeterville.
On November 12, 2026, the Company filed a Certificate of Amendment to amend its Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-5. The reverse stock split became effective on November 17, 2026. All share and per share amounts throughout the condensed consolidated financial statements have been retroactively adjusted to reflect this reverse stock split.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
FORWARD-LOOKING STATEMENTS
In addition to historical information, this Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which provides a “safe harbor” for forward-looking statements made by us. All statements, other than statements of historical facts, including statements concerning our plans, objectives, goals, beliefs, business strategies, future events, business conditions, results of operations, financial position, business outlook, business trends, and other information, may be forward-looking statements. Words such as “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “future,” “intend,” “may,” “might,” “plan,” “potential,” “projections,” “seek,” “should,” “will,” “would,” and variations of such words or similar expressions are intended to identify forward-looking statements. The forward-looking statements are not historical facts, and are based upon our current expectations, beliefs, estimates and projections, and various assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, estimates, and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that our expectations, beliefs, estimates, and projections will occur or can be achieved. Actual results may vary materially from what is expressed in or indicated by the forward-looking statements.
These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or anticipated results, including:
·
our history of losses and our ability to continue as a going concern;
our ability to obtain additional financing to fund our operations;
our ability to maintain the listing of our common stock on the Nasdaq Stock Market LLC (“Nasdaq”) and comply with Nasdaq’s listing standards;
the departure of members of our management team;
our market opportunity;
our ability to effectively manage our growth;
our ability to complete and integrate business acquisitions;
the effects of increased competition as well as innovations by new and existing competitors in our market;
our ability to retain our existing customers and to increase our customer base;
the future growth of the indoor agriculture industry and demands of our customers;
our ability to maintain, or strengthen awareness of, our brand;
our ability to expand the product lines we offer;
our ability to maintain, protect, and enhance our intellectual property;
future revenue, hiring plans, expenses and capital expenditures;
our ability to pay our debts as they come due;
our ability to comply with new or modified laws and regulations that currently apply or become applicable to our business;
our ability to recruit and retain key employees and management personnel;
our financial performance and capital requirements; and
the potential lack of liquidity and trading of our securities.
The following discussion should be read in conjunction with our financial statements and notes thereto included elsewhere in this report and our other reports filed with the Securities and Exchange Commission (“SEC”).
OVERVIEW
We are a controlled environment agriculture ("CEA") farming company. We use traditional agricultural growing techniques together with technology to grow fresh, organic food sustainably and safely while improving traceability. We operate glass, hydroponic, and vertical greenhouse structures that enable us to grow organic herbs consistently year-round while using less land, less energy, and less water than conventional agriculture. In our hydroponic greenhouse, we grow plants without soil. Instead of planting one row of plants in the ground, by using a vertical growing system, we can grow many towers of plants in the same area by planting up instead of planting across. Growing these products sustainably means that we avoid depleting natural resources in order to maintain an ecological balance, such as by renewing, reusing and recycling materials in order to lower the overall one-time use of materials. Our facilities utilize "closed loop" irrigation systems that recollect and reuse drain water—including water recycled through reverse osmosis—reducing overall water consumption and helping conserve natural resources. Our advanced systems are also designed to help mitigate contamination from harmful pathogens, including salmonella, e-coli and others.
Our operations are supported by GreenThumb®, our proprietary patented greenhouse management and demand-planning software (U.S. Patent Nos. 11,158,006 B1; 11,410,249 B2; and 11,830,088 B2). GreenThumb tracks plants through all stages of production and distribution, supporting quality control, traceability, fill-rate management, and logistics optimization, including maximizing truckload efficiency to reduce greenhouse gas emissions. We believe GreenThumb is a meaningful competitive differentiator and an important component of our Zero-Waste Inspired® model.
As of September 30, 2026, we offer more than 140 stock keeping units ("SKUs") spanning two principal product segments: (i) fresh produce, including cut herbs, hydroponic basil, potted herbs, and wheatgrass; and (ii) shelf-stable and refrigerated consumer packaged goods, including sports nutrition and nutraceuticals (Kick.™ and Vitamin Whey®/Vitamin Way®), fermented gourmet sauces and chili-based products (Pulp®), and functional fermented pickles and sauerkraut (Pickle Party™). We also supply products under private label arrangements to major retail customers. We have leveraged our brand recognition to offer co-manufactured consumer-packaged goods across protein, fermented foods, and flavoring categories in addition to our core fresh produce business. Our tagline "Simply Local, Simply Fresh" reflects our strategy of growing products in regional communities close to the retail locations where they are sold, extending shelf life and supporting local brand awareness.
Our products are available in over 7,000 retail locations across the United States, the Caribbean, and South America. We operate vertically integrated greenhouses and processing facilities at Edible Garden Heartland in Grand Rapids, Michigan; Edible Garden Prairie Hills in Webster City, Iowa; and our headquarters at Edible Garden Belvidere in Belvidere, New Jersey. We also partner with a network of contract growers strategically located near major U.S. population centers.
We hold food safety certifications from Primus GFS (a Global Food Safety Initiative ("GFSI")-accredited program), USDA Organic certification for applicable products, and non-GMO verification from the non-GMO Project for select SKUs. We are licensed under the Perishable Agricultural Commodities Act ("PACA") and voluntarily comply with Hazard Analysis Critical Control Point ("HACCP") principles established by the U.S. Food and Drug Administration.
We have a history of operating losses since inception and expect to incur additional near-term losses. Our auditors have issued an opinion expressing substantial doubt about our ability to continue as a going concern. See "Management's Discussion and Analysis — Liquidity and Capital Resources" for additional discussion of these matters.
Since our initial public offering, our primary business strategy has been focused on the production and sale of fresh, locally grown, USDA Organic produce through a vertically integrated CEA model. During the fiscal year ended December 31, 2025, and continuing into 2026, we began executing a material expansion and evolution of that strategy.
Specifically, we are transitioning our Edible Garden Prairie Hills facility in Webster City, Iowa into a dedicated ready-to-drink ("RTD") and clean nutrition manufacturing hub. This initiative represents a significant broadening of our business from primarily fresh, perishable produce into what we expect will be higher-margin, shelf-stable beverage and nutrition categories. We have characterized this evolution as the development of a vertically integrated domestic clean-label nutrition platform that combines our existing controlled-environment agriculture capabilities with scalable aseptic processing capacity and differentiated branded products across sports nutrition, adult and children's performance nutrition, and GLP-1 supportive categories.
This strategic shift, which we refer to as our "Farm-to-Formula®" strategy, connects our CEA-sourced ingredients with advanced research and development and precision formulation capabilities to deliver finished functional RTD beverages at commercial scale. This represents a material change from our previously disclosed strategy of focusing principally on fresh produce, and investors should consider the risks and opportunities associated with this expansion when evaluating our business.
On March 4, 2026, we entered into two Interim Order Agreements (the "IOAs") with Tetra Pak Inc. ("Tetra Pak"), a global leader in food processing and packaging solutions, to commence engineering services and preliminary procurement activities for the Webster City, Iowa production project (the "Project"). The IOAs cover both processing equipment and aseptic packaging systems and are intended as the initial step toward a definitive final supply agreement governing the full scope of equipment installation and integration.
The planned facility will utilize Tetra Pak's Tetra Prisma® Aseptic 330 Edge package—a format made primarily from renewable, plant-based materials that is designed to be recyclable—together with the Tetra Pak® A3/Speed filling platform. These systems are expected to extend product shelf life without refrigeration or preservatives prior to opening, support ambient distribution, maintain clean-label standards, and reduce overall supply chain costs and food waste.
Phase 1 production at the Webster City facility is anticipated to begin in 2027, subject to the execution of a final supply agreement with Tetra Pak, completion of engineering and installation, regulatory approvals, and adequate capital availability. There is no assurance that a final agreement will be executed, that the facility will be completed on the anticipated timeline, or that Phase 1 production will commence as planned. This initiative is in the early development stage, and investors should not place undue reliance on timing or scale projections, or our ability to complete the Project.
The Midwest facility encompasses more than 200,000 square feet of food-grade manufacturing space with warehousing and logistics infrastructure, and upon completion of the RTD buildout is expected to support aseptic and ultra-filtered beverage production across protein, plant-based, dairy, and functional categories. The Company intends for the facility to serve as a scalable innovation platform supporting product development and revenue diversification beyond fresh perishables.
RECENT DEVELOPMENTS
On August 11, 2026, we entered into an Equity Distribution Agreement (the “2026 EDA”) with Maxim Group LLC (“Maxim”) as sales agent, pursuant to which we may, from time to time, issue and sell shares of common stock through Maxim in an at-the-market offering for an aggregate offering price of up to $7,195,548. Under the terms of the 2026 EDA, Maxim may sell the shares at market prices by any method that is deemed to be an “at-the-market offering” as defined in Rule 415 under the Securities Act. The offering of shares of our common stock pursuant to the 2026 EDA will terminate upon the earliest of (i) August 11, 2027, (ii) the sale of all Shares provided for in the prospectus supplement related to this offering, and (iii) the termination of the EDA by written notice of us or Maxim. During the three months ended September 30, 2026, the company sold 71,912 shares for total proceeds of $513,421 and paid $15,879 in commissions to Maxim.
Square Roots Partnership
On August 24, 2026, we entered into a non-binding MOU with Square Roots Urban Growers to jointly develop clean-label, functional ready-to-drink beverages using nutrient-dense crops. The collaboration is intended to combine Square Roots' crop research and ingredient development with Edible Garden's beverage formulation and manufacturing capabilities.
Nasdaq Compliance
On August 31, 2026, the Company received a letter from Listing Qualifications Staff (the “Staff”) of Nasdaq indicating that we had regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of at least $1 per share (the “Bid Price Rule”), as required by the Nasdaq Hearings Panel’s decision dated July 27, 2026. Pursuant to the Letter, we will be subject to a “Panel Monitor,” as defined by Nasdaq Listing Rule 5815(d)(4)(B), through August 31, 2027. If we fail to satisfy the Bid Price Rule during the one-year monitoring period: (i) we will not be permitted to present a compliance plan to Nasdaq’s Listing Qualifications Department (the “Department”), (ii) the Department will not be permitted to grant any additional time for us to regain compliance with the deficiency, (iii) we will not be afforded an applicable cure or compliance period pursuant to Nasdaq Listing Rule 5810(c)(3), and (iv) the Department will promptly issue a delisting determination. As previously disclosed, the Nasdaq Hearing Panel will also maintain jurisdiction over our listing through November 23, 2026. During this period, if we do not maintain compliance with the Bid Price Rule, the Panel will immediately delist our securities from Nasdaq.
Supply Agreement
On October 16, 2026, we entered into a Produce Supply Agreement (the “Supply Agreement”) with Caney Fork Farms, LLC (the “Supplier”), effective as of October 15, 2026, pursuant to which we agreed to the general terms and conditions of purchasing certain fresh produce for its core herb business (the “Products”) from the Supplier and reselling, distributing and/or further processing the Products for sale to our customers. Under the Supply Agreement, we and the Supplier agreed to fixed pricing for Products through January 31, 2027. Thereafter, the parties will mutually agree to any annual price changes, provided that no annual price increase will exceed the lesser of (i) the percentage increase in the published Producer Price Index applicable to the Products or (ii) 10%. During the term of the Supply Agreement, we have a right of first offer regarding any proposed opportunities of the Supplier to commercialize, market, sell or supply fresh-cut herbs, potted herbs or hydro basil, upon which the parties shall negotiate in good faith regarding such items. The right of first offer applies to all of the Supplier’s opportunities to grow, source, process, manufacture, package, market, distribute, license, commercialize, or sell any Products or other fresh-cut herbs not currently covered by the Supply Agreement. The Supply Agreement remains in effect until October 15, 2028 and automatically renews for successive one year terms unless either party provides written notice of non-renewal at least 60 days prior to expiration. We may immediately terminate the Supply Agreement if the Supplier fails to meet food safety or performance standards under the Supply Agreement. Either party may terminate the Supply Agreement for cause after a 30-day cure period for resolving a breach of the agreement. After October 15, 2028, either party may terminate the Supply Agreement without cause upon 120 days’ prior written notice.
Prairie Hills Purchase
On September 30, 2026, we entered into a Purchase Contract with Iowa Shrimp Holdings, LLC, (the “Seller”), pursuant to which we agreed to purchase from the Seller our Prairie Hills Facility in Webster, Iowa. On October 30, 2026, pursuant to the Purchase Contract, we completed the acquisition of the Property (the “Closing”). At the Closing, the Seller conveyed the Property to Edible Garden Prairie Hills LLC, a Delaware limited liability company and our wholly owned subsidiary (“Prairie Hills”). At the direction of the Seller, we issued to Streeterville 1,000 shares of our Series B Preferred Stock, which the parties assigned an agreed value of $1,000,000, and we issued to Streeterville a secured promissory note in the original principal amount of $3,825,000 (the “Note”). The Note matures five years after the date of issuance and bears interest at a rate of 8% per annum, compounded daily. Our obligations under the Note are secured by a real estate mortgage on the Property granted by Prairie Hills in favor of Streeterville (the “Mortgage”). Together with the 1,500 shares of Series B Preferred Stock previously issued by us to Streeterville on September 30, 2026, which the parties assigned an agreed value of $1,500,000, the aggregate purchase price for the Property was $6,325,000.
Reverse Stock Split
On November 12, 2026, the Company filed a Certificate of Amendment to amend its Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-5. The reverse stock split became effective on November 17, 2026.
CRITICAL ACCOUNTING ESTIMATES
The preparation of the unaudited consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to use judgment in making estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses. The following accounting policies are based on, among other things, judgments and assumptions made by management that include inherent risks and uncertainties. Management’s estimates are based on historical experience, the relevant information available at the end of each period, and their judgment. Although management believes the judgment applied in preparing estimates is reasonable based on circumstances and information known at the time, actual results could differ materially from these estimates under different assumptions or market conditions.
The most significant accounting estimates involve a high degree of judgment or complexity. Management believes the estimates and judgments most critical to the preparation of our condensed consolidated financial statements and to the understanding of our reported financial results include allowance for doubtful accounts. The following are the accounting estimates most critical to the preparation of our condensed consolidated financial statements.
Revenue Recognition
Revenues are recognized when control of the promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.
We do not offer returns, discounts, loyalty programs or other sales incentive programs that are material to revenue recognition. Payments from our customers are due upon delivery or within a short period after delivery.
Property, Equipment and Leasehold Improvements
Property, equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. Our fixed assets, which are comprised of leasehold improvements, equipment and vehicles, have useful lives of five years.
Expenditures for major renewals and improvements are capitalized, while minor replacements, maintenance and repairs, which do not extend the asset lives, are charged to operations as incurred. Upon sale or disposition, the cost and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. We continually monitor events and changes in circumstances that could indicate that the carrying balances of its property, equipment and leasehold improvements may not be recoverable in accordance with the provisions of Accounting Standards Codification (“ASC”) 360, “Property, Plant, and Equipment.” When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. See Note 4, “Property, Equipment and Leasehold Improvements, Net” for further information.
The provision for income taxes is determined in accordance with ASC 740, “Income Taxes.” We file a consolidated United States federal income tax return. We provide for income taxes based on enacted tax law and statutory tax rates at which items of income and expense are expected to be settled in our income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. We incurred net operating losses for financial-reporting and tax-reporting purposes.
We recognize uncertain tax positions based on a benefit recognition model. Provided that the tax position is deemed more likely than not of being sustained, the Company recognizes the largest amount of tax benefit that is greater than 50.0% likely of being ultimately realized upon settlement. The tax position is derecognized when it is no longer more likely than not of being sustained. The Company classifies income tax related interest and penalties as interest expense and selling, general and administrative expense, respectively, on the consolidated statements of operations.
RESULTS OF OPERATIONS
COMPARISON OF THE THREE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
September 30
5,614
6,375
Revenue
Revenue was $3.2 million for the three months ended September 30, 2026, compared to $2.8 million for the three months ended September 30, 2025. The increase in revenue of $0.4 million, or 14%, is primarily attributable to continued growth in our cut herb portfolio across our retail client base, as well as expansion into new locations of existing customers.
Operating expenses
Operating expenses were $5.6 million for the three months ended September 30, 2026, compared to $6.4 million for the three months ended September 30, 2025. The decrease of $0.8 million or 11.9% was primarily due to decrease in selling, general, and administrative expenses. The decrease in SG&A was primarily driven by a $0.5 million reduction in bad debt expense, as sales shifted towards customers with stronger credit and payment terms. SG&A was secondarily driven by a reduction in audit and accounting fees. Further, cost of goods sold was $2.4 million for the three months ended September 30, 2026, compared to $2.5 million for the three months ended September 30, 2025. The decrease of $0.1 million or 4% is primarily due to the shift in percentage of sales attributed to cut herbs, allowing us to take advantage of the economies of scale both for third party supplier orders that were previously more expensive in smaller quantities, as well as more efficient labor in the greenhouse.
Loss from operations were $2.4 million for the three months ended September 30, 2026, compared to $3.6 million for the three months ended September 30, 2025. The decrease in the loss from operations of $1.2 million or 32.4% was driven by higher overall sales and lower SG&A expense.
Interest expense
Interest expense was $296 thousand for the three months ended September 30, 2026, compared to $387 thousand for the three months ended September 30, 2025. The decrease of $91 thousand or 23.5% was primarily due to the decreased average interest rate.
Net loss was $2.4 million for the three months ended September 30, 2026, compared to a net loss of $4.0 million for the three months ended September 30, 2025. The reasons for the decrease in net loss are explained above.
COMPARISON OF THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025
22,360
18,758
Revenue was $10.1 million for the nine months ended September 30, 2026, compared to $8.7 million for the nine months ended September 30, 2025. The increase in revenue of $1.4 million, or 16.4%, is primarily attributable to continued growth in our cut herb portfolio across our retail client base, as well as expansion into new locations of existing customers.
Operating Expenses
Operating expenses were $22.4 million for the nine months ended September 30, 2026, compared to $18.8 million for the nine months ended September 30, 2025. The increase of $3.6 million or 19.2% was primarily due to a $2.8 million or 220.4% increase in depreciation and amortization from accelerated depreciation of certain fixed assets related to the Company's pivot to RTD clean nutrition manufacturing, earlier in the year. Cost of goods sold increased $2.1 million or 27.3%, primarily due to supplier issues, leading to increased product pricing earlier in the year, as well as product mix requiring more labor to manage the various areas. These were partially offset by a reduction in legal and audit and accounting fees.
Loss from operations were $12.3 million for the nine months ended September 30, 2026, compared to $10.1 million for the nine months ended September 30, 2025. The increase in the loss from operations was driven by higher overall expenses across cost of goods sold and depreciation expense.
Interest expense was $0.6 million for the nine months ended September 30, 2026, compared to $1.2 million for the nine months ended September 30, 2025. The decrease of $0.6 million was primarily due to the decreased effective interest rate.
Income tax benefit was $3.4 million for the nine months ended September 30, 2026. We transferred state tax benefit to a third-party buyer in exchange for cash consideration and recorded a gain driven primarily due to valuation allowance release.
Net loss was $9.4 million for the nine months ended September 30, 2026, compared to a net loss of $11.4 million for the nine months ended September 30, 2025. The reasons for the decrease in net loss are explained above.
LIQUIDITY AND CAPITAL RESOURCES
Going Concern Considerations
We have incurred significant losses since our inception. We recognized net losses of approximately $9.4 million during the nine months ended September 30, 2026 and $17.3 million during the year ended December 31, 2025. We expect our capital expenses and operational expenses to increase in the future due to expected increased sales and marketing expenses, operational costs, and general and administrative costs. Therefore, we believe our operating losses will continue or even increase at least through the near term.
The risks and uncertainties surrounding our ability to continue our business with limited capital resources raises substantial doubt as to our ability to continue as a going concern for twelve months from the issuance of these financial statements. To date, we have financed our operations with the proceeds from debt financings, public and private securities offerings, and operations, among other sources. If we are unable to raise additional capital, we believe that our existing cash will fund operations into the fourth quarter of 2026 and will not be sufficient to fund our operations through the next twelve months beyond the date of the issuance of our consolidated financial statements. Our operations have consumed substantial amounts of cash since inception. The net cash used in operating activities was $3.8 million during the nine months ended September 30, 2026. Our financial statements have been prepared on a “going concern” basis. However, substantial doubt exists regarding our ability to continue as a going concern for the next twelve months. Our consolidated financial statements do not include any adjustments that might result if we are unable to continue as a going concern. If we are unable to continue as a going concern, holders of our securities might lose their entire investment. These factors, among others, may make it difficult to raise any additional capital and may cause us to be unable to continue to operate our business.
There is no assurance that we will ever be profitable or that debt or equity financing will be available to us in the amounts, on terms, and at times deemed acceptable to us, if at all. The issuance of additional equity or equity-linked securities by us would result in significant dilution of the equity interests of our current stockholders. Obtaining commercial loans, assuming those loans would be available, would increase our liabilities and future cash commitments. If we are unable to obtain financing in the amounts and on terms deemed acceptable to us, we may be unable to continue our business as planned and as a result may be required to scale back or cease operations, which could cause our stockholders to lose some or all of their investment in us. The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should we be unable to continue as a going concern.
Liquidity
The Company’s primary liquidity requirements are for working capital, continued investments in capital expenditures, repayment of indebtedness, and other strategic investments. Although income taxes are not currently a significant use of funds, after the benefits of our net operating loss carryforwards are fully recognized, they could become a material use of funds, depending on our future profitability and future tax rates. The Company’s liquidity needs have been met primarily through public equity offerings, term loan borrowings, accounts receivable financing, convertible notes, and related party loans.
As of September 30, 2026 and December 31, 2025, we had $1.2 million and $1.1 million in cash and cash equivalents available, respectively. During the nine months ended September 30, 2026, cash used in operating activities was $3.8 million. As of September 30, 2026 and December 31, 2025, we had $14.1 million and $1.7 million of total debt outstanding, respectively.
We may not be able to access the capital markets in the future on commercially acceptable terms or at all. Our ability to fund future operating expenses and capital expenditures and our ability to meet future debt service obligations or refinance our indebtedness will depend on our future operating performance, which will be affected by general economic, financial and other factors beyond our control, including those described under “Risk Factors” in our Annual Report on Form 10-K, filed with the SEC on March 31, 2026.
Capital Resources
In January 2026, we completed the sale of certain New Jersey state net operating loss carryforwards under the New Jersey Economic Development Authority's Technology Business Tax Certificate Transfer Program, which had resulted in a deferred tax asset of approximately $3.4 million, in exchange for gross proceeds of approximately $3.1 million, resulting in net cash proceeds of approximately $3.0 million after transaction-related costs of approximately $0.1 million.
On March 3, 2026, we entered into a Note Purchase Agreement with Streeterville Capital, LLC ("Streeterville"), pursuant to which we issued to Streeterville a secured promissory note in the principal amount of $1.6 million (the "Streeterville Note"), which included an original issue discount of $120 thousand and reimbursement of Streeterville's transaction expenses of $5 thousand, for a purchase price of $1.5 million. The Streeterville Note bears interest at a rate of 8.0% per annum and matures 13 months after its issuance date.
On June 12, 2026, the Company entered into a Notes Purchase Agreement with Streeterville pursuant to which it issued (i) a Promissory Note A-1 with an original principal amount of $2.17 million and (ii) a Secured Promissory Note B with an original principal amount of $10.0 million. The notes mature eighteen months from issuance. The A-1 Note bears interest at 8% per annum, while the B Note bears interest at 5% per annum.
On August 11, 2026, we entered into the 2026 EDA with Maxim, as sales agent, pursuant to which the Company may, from time to time, issue and sell shares of its common stock through Maxim in an at-the-market offering for an aggregate offering price of up to $7,195,548. To date, we have received net proceeds of $498,018 from the sale of common stock under the 2026 EDA after deducting Maxim’s commission of 3.0% of the gross proceeds and other offering expenses.
On October 30, 2026, the Company issued to Streeterville a secured promissory note in the original principal amount of $3,825,000 (the “Note”). The Note matures five years after the date of issuance and bears interest at a rate of 8% per annum, compounded daily. The Company’s obligations under the Note are secured by a real estate mortgage on the Property granted by Prairie Hills in favor of Streeterville (the “Mortgage”). See Note 14, “Subsequent Events,” for further discussion.
We expect to continue to incur losses and negative cash flows from operations for the foreseeable future. We may seek to raise additional capital through equity or debt financings, sales of assets, or other strategic alternatives. There can be no assurance that any additional financing will be available on acceptable terms, or at all. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly reduce our operations or delay, scale back or discontinue the development of one or more of our products or operations.
For more information on our outstanding debt as of September 30, 2026 and December 31, 2025, see Note 7 “Notes Payable.”
Cash Flows
Operating activities
During the nine months ended September 30, 2026, cash used for operating activities was $3.8 million. During the nine months ended September 30, 2025, cash used for operating activities was $9.1 million. For the period ended September 30, 2026, the net loss of $9.4 million was partially offset by accelerated depreciation of certain fixed assets related to Company’s pivot to RTD manufacturing of $2.7 million, and amortization of operating lease right of use assets related to Natural Shrimp totaling $0.7 million. For the period ended September 30, 2025, the net loss of $11.4 million was offset by depreciation and amortization expense, as well as amortization of debt discount totaling $1.2 million.
Investing activities
During the nine months ended September 30, 2026 and 2025, cash used in investing activities was $4.4 million and $0.5 million, respectively. The increase is related to the cash flow impact of the acquisition and build out of the Prairie Hills, IA facility and the related construction in progress of $4.2 million.
Financing activities
During the nine months ended September 30, 2026 and 2025, cash provided by financing activities was $12.6 million and $7 million, respectively. The increase is driven by $13.8 million generated by the Streeterville Notes, offset by $1.7 million of debt repayments and $34 thousand of lease payments.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As a smaller reporting company, we are not required to provide the information required by this item.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
Our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2026 pursuant to Rule 13a-15 under the Exchange Act. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2026, our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) were effective as of September 30, 2026, at the reasonable assurance level.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
ITEM 1A. RISK FACTORS
In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should consider the risks described in Part I, Item 1A, "Risk Factors" of our Annual Report on Form 10-K for the year ended December 31, 2025. Except as set forth below, there have been no material changes from the risk factors previously disclosed in the Annual Report on Form 10-K. Any of these risks and uncertainties, including those discussed below, could materially and adversely affect our business, results of operations, financial condition, and/or the market price of our common stock. The risks described below and in our Annual Report on Form 10-K, are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our financial condition and/or operating results.
There can be no assurance that our shares will continue to be listed on Nasdaq, which would affect our common stock’s liquidity and reduce our ability to raise capital.
On July 22, 2026, the SEC approved a new continued listing requirement codified as Nasdaq Listing Rule 5550(a)(6) that requires companies to maintain a market value of listed securities of at least $5 million (the “MVLS Requirement”). On July 29, 2026, the SEC provided notice that the order approving the MVLS Requirement was stayed pending a petition for review of the action. On September 11, 2026, the SEC announced it is reviewing the approval of the MVLS Requirement. The implementation of the MVLS Requirement remains stayed until the SEC orders otherwise. As of September 30, 2026, we are not in compliance with the MVLS Requirement if it were to come into effect. Under Nasdaq Listing Rule 5810(c)(1), if the MVLS Requirement comes into effect and we fail to meet the MVLS Requirement for 30 consecutive business days, our securities will be suspended and immediately delisted from the Nasdaq Capital Market, even if we are appealing a delisting determination to a Panel, and the Panel will have limited discretion to reverse the delisting determination if it was issued in error or grant an exception for up to 180 days for us to demonstrate compliance with all requirements for initial listing on Nasdaq. Additionally, pursuant to the Panel’s decision relating to our delisting appeal, the Panel will maintain jurisdiction over our listing status until November 23, 2026, and if we become non-compliant with any other listing rule, aside from the Bid Price Rule, during this time period, we will be allowed seven calendar days to advise the Panel on our plan to cure the listing deficiency, and the Panel will, at that time, determine whether to grant us an exception to cure the deficiency or delist our securities from Nasdaq. This includes the MVLS Requirement.
We cannot assure you that we will be able to regain compliance with the MVLS Requirement and maintain compliance with Nasdaq’s other continued listing standards. Accordingly, our common stock and certain warrants could be delisted from Nasdaq. We and holders of our securities could be materially adversely impacted if our securities are delisted from Nasdaq. In particular:
we may be unable to raise equity capital on acceptable terms or at all;
we may lose the confidence of our customers, which would jeopardize our ability to continue our business as currently conducted;
the price of our common stock will likely decrease as a result of the loss of market efficiencies associated with Nasdaq and the loss of federal preemption of state securities laws;
holders may be unable to sell or purchase our securities when they wish to do so;
we may become subject to stockholder litigation;
we may lose the interest of institutional investors in our common stock;
we may lose media and analyst coverage;
our common stock could be considered a “penny stock,” which would likely limit the level of trading activity in the secondary market for our common stock; and
we would likely lose any active trading market for our common stock, as it may only be traded on one of the over-the-counter markets, if at all.
ITEM 6. EXHIBITS
Incorporated by Reference
Exhibit
Number
Description
Form
File No.
Filing
Date
3.1
Certificate of Amendment to the Certificate of Incorporation, filed July 8, 2026.
8-K
001-41371
July 9, 2026
3.2
Certificate of Amendment to the Certificate of Incorporation, filed November 12, 2026.
November 13, 2026
10.1±#
Purchase Agreement dated as of January 1, 2027 by and between the Company and Meijer Distribution, Inc.
August 3, 2026
10.2±
Equity Distribution Agreement, dated August 11, 2026, by and between Edible Garden AG Incorporated and Maxim Group LLC.
August 11, 2026
10.3±
Real Estate Purchase Contract, dated September 30, 2026, by and between Iowa Shrimp Holdings, LLC and Edible Garden AG Incorporated.
October 1, 2026
10.4
Form of Secured Promissory Note to be issued by Edible Garden AG Incorporated in favor of Streeterville Capital, LLC.
10.5±
Supply Agreement, dated October 16, 2026, by and between Caney Fork Farms, LLC and Edible Garden AG Incorporated.
October 22, 2026
31.1
Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Filed herewith
31.2
Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Furnished herewith
101
Materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, formatted in Extensible Business Reporting Language (XBRL); (i) Unaudited Consolidated Balance Sheet, (ii) Unaudited Consolidated Statements of Operations, (iii) Unaudited Consolidated Statements of Cash Flows, (iv) Unaudited Consolidated Statements of Stockholders’ Deficit, and (v) related Notes to Consolidated Financial Statements.
104
Cover Page Interactive Data File (included in Exhibit 101).
# Certain portions of this exhibit have been omitted (indicated by asterisks) pursuant to Item 601(b)(10) of Regulation S-K because the omitted information is (i) not material and (ii) the type of information that the Company treats as private or confidential.
± Certain information has been omitted from this exhibit in reliance upon Item 601(a)(5) of Regulation S-K and will be furnished to the Securities and Exchange Commission upon request.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
By:
/s/ James E. Kras
James E. Kras
Chief Executive Officer and President
(principal executive officer)
/s/ Jonathan Gutoski
Jonathan Gutoski
Chief Financial Officer
(principal financial and accounting officer)
Date: November 20, 2026